Elevated circulating fasting glucagon-like peptide-1 in surgical patients with aortic valve disease and diabetes
Abstract Background Diabetes is a risk factor for peripheral, coronary, and cerebrovascular disease. In contrast, results also indicate that patients with diabetes have reduced prevalence of aortic aneurysms, although the mechanisms remain largely unknown. We hypothesize that altered endogenous secr...
Main Authors: | Camilla Krizhanovskii, Stelia Ntika, Christian Olsson, Per Eriksson, Anders Franco-Cereceda |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | Diabetology & Metabolic Syndrome |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13098-017-0279-0 |
Similar Items
-
Syndecan-1 Expression Is Increased in the Aortic Wall of Patients with Type 2 Diabetes but Is Unrelated to Elevated Fasting Plasma Glucagon-Like Peptide-1
by: Stelia Ntika, et al.
Published: (2021-06-01) -
Decreased Glucagon-Like Peptide-1 Is Associated With Calcific Aortic Valve Disease: GLP-1 Suppresses the Calcification of Aortic Valve Interstitial Cells
by: Fan Xiao, et al.
Published: (2021-08-01) -
Discovering the link between bicuspid aortic valve and aortic aneurysms: genetic or hemodynamic?
by: Habchi, Karam
Published: (2016) -
Managing Thoracic Aortic Aneurysm in Patients with Bicuspid Aortic Valve Based on Aortic Root-Involvement
by: Elizabeth Norton, et al.
Published: (2017-06-01) -
Aortic Valve replacement with Reduction Aortoplasty with Mesh Prosthesis in 75 years old with Sever aortic Regurgitation with Aortic Aneurysm
by: Hamid Hoseinikhah, et al.
Published: (2020-09-01)